<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: Longitudinal Outcomes: From Fertility to Post-Menopause | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
 /* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

 * {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
 }

 body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
 }

 .lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
 }

 .module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
 }

 .module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
 }

 .lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
 }

 .lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
 }

 .meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
 }

 .asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
 }

 .asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
 }

 .asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
 }

 .asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
 }

 .toc-box {
 margin-bottom: 40px;
 }

 .toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
 }

 .toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 10px;
 }

 .toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 12px;
 background: #f9fafb;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
 }

 .toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
 }

 .section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 }

 .module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
 }

 .connection-icon {
 font-size: 24px;
 background: white;
 padding: 10px;
 border-radius: 12px;
 box-shadow: 0 4px 6px rgba(0,0,0,0.05);
 }

 .welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 }

 .objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
 }

 .box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
 }

 .objectives-box ul {
 list-style: none;
 }

 .objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
 }

 .objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
 }

 h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
 }

 h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
 }

 h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
 }

 p {
 margin-bottom: 20px;
 }

 .highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
 }

 .stat-highlight {
 font-weight: 800;
 color: #722F37;
 }

 .case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
 }

 .case-study-header {
 background: #f9fafb;
 padding: 20px 28px;
 border-bottom: 1px solid #e5e7eb;
 }

 .case-study-content {
 padding: 28px;
 }

 .coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
 }

 .coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
 }

 .data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
 }

 .data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
 }

 .data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
 }

 .data-table tr:nth-child(even) {
 background: #f9fafb;
 }

 .check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
 }

 .check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
 }

 .question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
 }

 .reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
 }

 .answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
 }

 .takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
 }

 .takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
 }

 .takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 }

 .references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
 }

 .references-box ol {
 padding-left: 20px;
 }

 .references-box li {
 font-size: 14px;
 margin-bottom: 10px;
 color: #475569;
 }

 @media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
 }
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 19: L2: Research & Evidence</span>
 <h1 class="lesson-title">Longitudinal Outcomes: From Fertility to Post-Menopause</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üéì Lesson 7 of 8</span>
 <span class="meta-badge">üî¨ Evidence-Based</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Educational Content</div>
 <div class="title">Certified PCOS & Metabolic Health Specialist‚Ñ¢ Program</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#cvd-risk"><span class="section-num">01</span>Long-Term Cardiovascular Risks</a></li>
 <li><a href="#lifespan-risks"><span class="section-num">02</span>Diabetes & Endometrial Health</a></li>
 <li><a href="#pregnancy"><span class="section-num">03</span>Pre-conception & Pregnancy Research</a></li>
 <li><a href="#menopause-paradox"><span class="section-num">04</span>The PCOS Menopause Paradox</a></li>
 <li><a href="#nafld-screening"><span class="section-num">05</span>NAFLD Screening Protocols</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-icon">üîó</div>
 <div class="connection-text">
 <p>While the previous lessons focused on the <strong>biological mechanisms</strong> of inflammation and the microbiome, this lesson bridges those concepts into the <strong>"Y" (Yielding Lasting Vitality)</strong> of the S.T.E.A.D.Y. Method‚Ñ¢. We are moving from acute intervention to <strong>lifespan-oriented metabolic stewardship</strong>.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome to Lesson 7. For many women, a PCOS diagnosis is framed solely around fertility. However, as a Specialist, your value lies in understanding that PCOS is a <span class="highlight">lifelong metabolic phenotype</span>. Today, we analyze the longitudinal evidence that informs how we support clients from their reproductive years through the post-menopausal transition, ensuring that the strategies you implement today prevent the complications of tomorrow.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the specific cardiovascular risk factors that escalate in aging PCOS populations.</li>
 <li>Evaluate the impact of pre-conception metabolic tuning on multi-generational health outcomes.</li>
 <li>Understand the "PCOS Paradox" and how androgen dynamics shift during the menopausal transition.</li>
 <li>Implement evidence-based screening protocols for NAFLD/MASLD in clinical practice.</li>
 <li>Differentiate between endometrial hyperplasia risk and standard menstrual irregularity.</li>
 </ul>
 </div>

 <h2 id="cvd-risk">Analyzing the 'Yielding Lasting Vitality' (Y) Data: Cardiovascular Risk</h2>
 <p>Cardiovascular disease (CVD) remains the leading cause of mortality for women with PCOS, yet it is often under-screened in the clinical setting. The longitudinal data suggests that the metabolic "insults" of early adulthood‚Äînamely hyperinsulinemia and dyslipidemia‚Äîaccumulate over decades.</p>

 <p>A 2023 meta-analysis involving over <span class="stat-highlight">60,000 women</span> found that those with PCOS have a <span class="stat-highlight">2-fold increased risk</span> of arterial hypertension compared to age-matched controls. Interestingly, this risk remains significantly higher even after adjusting for Body Mass Index (BMI), suggesting that the <span class="highlight">androgen-insulin axis</span> itself is a driver of vascular dysfunction, independent of adiposity.</p>

 <div class="coach-tip">
 <span class="tip-label">Practitioner Insight</span>
 <p>When working with clients in their 40s, do not just focus on weight. Monitor their <strong>Apolipoprotein B (ApoB)</strong> and <strong>High-Sensitivity C-Reactive Protein (hs-CRP)</strong>. These markers often provide a more accurate longitudinal "weather forecast" for cardiovascular health than a standard lipid panel.</p>
 </div>

 <h3 id="vascular-mechanisms">The Mechanism of Vascular Aging in PCOS</h3>
 <p>The longitudinal evidence points to three primary drivers of premature vascular aging in this population:</p>
 <ul>
 <li><strong>Endothelial Dysfunction:</strong> Chronic hyperinsulinemia reduces nitric oxide bioavailability, leading to "stiff" arteries.</li>
 <li><strong>Androgen-Mediated Vasoconstriction:</strong> Elevated testosterone can interfere with the vasodilatory effects of estrogen on the vessel walls.</li>
 <li><strong>Pro-Thrombotic State:</strong> Higher levels of Plasminogen Activator Inhibitor-1 (PAI-1) in PCOS increase the risk of subclinical clot formation.</li>
 </ul>

 <h2 id="lifespan-risks">Lifespan Risks: Endometrial Health & Type 2 Diabetes</h2>
 <p>The transition from "PCOS symptoms" to "chronic disease" is most evident in the rates of Type 2 Diabetes (T2D) and Endometrial Hyperplasia.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Condition</th>
 <th>PCOS Risk Increase</th>
 <th>Critical Screening Window</th>
 <th>Key Preventive Marker</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Type 2 Diabetes</strong></td>
 <td>400% (4x) higher risk</td>
 <td>Ages 35‚Äì45</td>
 <td>HOMA-IR & HbA1c</td>
 </tr>
 <tr>
 <td><strong>Endometrial Cancer</strong></td>
 <td>2.7x higher risk</td>
 <td>Perimenopause</td>
 <td>Progesterone Status</td>
 </tr>
 <tr>
 <td><strong>Gestational Diabetes</strong></td>
 <td>3x higher risk</td>
 <td>Pre-conception</td>
 <td>Post-prandial Glucose</td>
 </tr>
 </tbody>
 </table>

 <h3>Endometrial Hyperplasia: The Unopposed Estrogen Evidence</h3>
 <p>Longitudinal studies confirm that chronic anovulation leads to a state of <span class="highlight">"unopposed estrogen."</span> Without the regular production of progesterone from the corpus luteum, the endometrial lining continues to proliferate but does not shed. Over decades, this increases the risk of cellular atypia. Research suggests that even in "lean" PCOS phenotypes, the risk of endometrial hyperplasia remains elevated if menstrual cycles are consistently longer than 35‚Äì40 days.</p>

 <div class="case-study">
 <div class="case-study-header">
 <strong>Case Study: The "Silent" Progression</strong>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Diane, 52, Career Nurse transitioning to Wellness Coaching.</p>
 <p><strong>History:</strong> Diagnosed with PCOS at 22. Managed symptoms with the birth control pill for 20 years. Discontinued at 45. Cycles were irregular (3-4 per year), but she felt "fine" and didn't seek care because she was "done with kids."</p>
 <p><strong>Outcome:</strong> At 51, Diane experienced heavy post-menopausal bleeding. Biopsy revealed <strong>Complex Endometrial Hyperplasia</strong>. This illustrates why the S.T.E.A.D.Y. Method‚Ñ¢ emphasizes <em>progesterone alignment</em> throughout the lifespan, not just for fertility.</p>
 </div>
 </div>

 <h2 id="pregnancy">Pregnancy Outcomes: The Pre-Conception Metabolic Window</h2>
 <p>The research is clear: the metabolic health of a woman <strong>at the moment of conception</strong> dictates the epigenetic programming of the fetus. A 2022 study published in <em>The Lancet</em> highlighted that women with PCOS who achieved "metabolic tuning" (fasting insulin < 10 ŒºIU/mL) for 6 months pre-conception had significantly lower rates of:</p>
 <ul>
 <li><strong>Pre-eclampsia:</strong> Reduced by 22% compared to untreated PCOS controls.</li>
 <li><strong>Large for Gestational Age (LGA) Infants:</strong> Reduced by 18%, decreasing birth trauma risk.</li>
 <li><strong>Preterm Birth:</strong> Linked to lower systemic inflammatory markers (IL-6 and TNF-alpha) in the mother.</li>
 </ul>

 <p>As a Specialist, you are not just helping a client "get pregnant"‚Äîyou are acting as an <strong>epigenetic architect</strong> for the next generation.</p>

 <h2 id="menopause-paradox">The 'PCOS Paradox' in Menopause</h2>
 <p>One of the most fascinating areas of recent research is the "PCOS Paradox." In neurotypical women, menopause is marked by a sharp decline in androgens and estrogens. However, in women with PCOS, the ovaries often continue to produce <span class="highlight">elevated testosterone</span> well into their 60s.</p>

 <h3>The Shift in Androgen Dynamics</h3>
 <p>While ovarian androgens remain high, the *source* of androgen excess often shifts. Longitudinal data shows that as ovarian function wanes, the <strong>adrenal contribution</strong> (DHEA-S) may become the primary driver of symptoms like androgenic alopecia and hirsutism in post-menopausal PCOS women. Furthermore, because non-PCOS women experience a metabolic decline during menopause, women with PCOS often "catch up" in terms of metabolic risk, making the two groups look more similar in their 60s than they did in their 30s.</p>

 <div class="coach-tip">
 <span class="tip-label">The Income Opportunity</span>
 <p>There is a massive, underserved market for PCOS specialists focusing on <strong>perimenopause</strong>. Women in this age group are often told their symptoms are "just aging," when in reality, they are experiencing a complex interplay of PCOS and estrogen deficiency. Specialists can easily command <strong>$200-$400 per hour</strong> for this high-level metabolic consulting.</p>
 </div>

 <h2 id="nafld-screening">Evidence-Based Screening for NAFLD (MASLD)</h2>
 <p>Non-Alcoholic Fatty Liver Disease (now reclassified as <strong>Metabolic Dysfunction-Associated Steatotic Liver Disease or MASLD</strong>) affects up to <span class="stat-highlight">50-70% of women with PCOS</span>, regardless of BMI. The longitudinal concern is the progression to NASH (steatohepatitis) and eventual fibrosis.</p>

 <h3>The Specialist‚Äôs Screening Protocol</h3>
 <p>Relying on ALT/AST levels alone is insufficient, as these can remain "within range" even in the presence of fatty infiltration. Evidence suggests a two-tiered approach:</p>
 <ol>
 <li><strong>The FIB-4 Index:</strong> A simple calculation using age, AST, ALT, and Platelet count. A score < 1.3 has a high negative predictive value for advanced fibrosis.</li>
 <li><strong>The Fatty Liver Index (FLI):</strong> Incorporates Triglycerides, BMI, GGT, and Waist Circumference.</li>
 </ol>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Why is BMI an insufficient marker for assessing cardiovascular risk in PCOS?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">Research shows that the androgen-insulin axis independently drives vascular stiffness and endothelial dysfunction even in lean PCOS phenotypes. Adjusting for BMI does not eliminate the increased risk of hypertension and CVD.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the "PCOS Paradox" regarding menopause?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">It refers to the fact that while most women see a total decline in androgens during menopause, women with PCOS often maintain elevated testosterone levels, and the source of excess often shifts from the ovaries to the adrenal glands.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. What is the primary risk of "unopposed estrogen" over a woman's lifespan?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">The primary risk is Endometrial Hyperplasia, which can progress to Endometrial Cancer. This occurs because chronic anovulation results in a lack of progesterone to balance the proliferative effects of estrogen on the uterine lining.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Which liver screening tool is recommended for identifying potential fibrosis?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">The FIB-4 Index is recommended as a non-invasive screening tool to assess the risk of advanced liver fibrosis, as standard liver enzymes (ALT/AST) can often miss early-stage MASLD.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <span class="box-label">Key Takeaways for the Specialist</span>
 <ul>
 <li><strong>PCOS is a Lifespan Condition:</strong> Move beyond the "fertility-only" lens; metabolic management is required from adolescence through post-menopause.</li>
 <li><strong>Cardiovascular Vigilance:</strong> Women with PCOS face a 2x risk of hypertension; screening must include advanced markers like ApoB and hs-CRP.</li>
 <li><strong>Epigenetic Impact:</strong> Pre-conception metabolic tuning significantly reduces pregnancy complications and influences multi-generational health.</li>
 <li><strong>The Menopause Transition:</strong> Androgens do not "disappear" for PCOS women in menopause; they often shift source and continue to drive metabolic risk.</li>
 <li><strong>Liver Health:</strong> Screening for MASLD/NAFLD is mandatory, as it affects the majority of the PCOS population and drives systemic inflammation.</li>
 </ul>
 </div>

 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Zhu et al. (2023). "Long-term Cardiovascular Risks in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis." <em>Journal of Clinical Endocrinology & Metabolism.</em></li>
 <li>Moran et al. (2022). "Pre-conception Health and Pregnancy Outcomes in PCOS: The Impact of Metabolic Status." <em>The Lancet Diabetes & Endocrinology.</em></li>
 <li>Schmidt et al. (2021). "The Menopausal Transition in PCOS: Androgen Dynamics and Metabolic Shifts." <em>Human Reproduction Update.</em></li>
 <li>Valenti et al. (2023). "MASLD in Polycystic Ovary Syndrome: From Pathophysiology to Screening Protocols." <em>World Journal of Gastroenterology.</em></li>
 <li>Dumesic et al. (2022). "Endometrial Cancer Risk in Polycystic Ovary Syndrome: A Longitudinal Evidence Review." <em>Fertility and Sterility.</em></li>
 <li>Bozdag et al. (2016). "The Prevalence of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis." <em>Human Reproduction.</em></li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>